Pregnancy-associated plasma protein-a, a marker for outcome in patients suspected for acute coronary syndrome

Clinical Biochemistry

Volumn 43, Issue 10-11, 2010, Pages 851-857

  Iversen, Kasper K ^a   Dalsgaard, Morten ^a   Teisner, Ane S ^b   Schoos, Mikkel ^a   Teisner, Borge ^c,d   Nielsen, Henrik ^b   Grande, Peer ^e   Clemmensen, Peter ^e  

^a HILLERØD HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c London Bridge Fertility   (United Kingdom)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Acute coronary syndrome; Pregnancy associated plasma protein A; Prognosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FATALITY; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; THORAX PAIN; UPREGULATION; BLOOD; KAPLAN MEIER METHOD; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEST PAIN; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT; KAPLAN-MEIER ESTIMATE;

EID: 77953709865     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.03.018     Document Type: Article

References (39)

1. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
2. Consuegra-Sanchez L., Petrovic I., Cosin-Sales J., Holt D.W., Christiansen M., Kaski J.C. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin Chim Acta 2008, 391:18-23.
3. Conti E., Andreotti F., Zuppi C. Pregnancy-associated plasma protein a as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 2004, 109:e211-e212.
4. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004, 109:1724-1728.
5. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005, 45:229-237.
6. Iversen K.K., Teisner A.S., Teisner B., Kliem A., Thanning P., Grande P., et al. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am J Cardiol 2008, 101:1389-1394.
7. Khosravi J., Diamandi A., Krishna R.G., Bodani U., Mistry J., Khaja N. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. Clin Biochem 2002, 35:531-538.
8. Li X.P., Zhou S.H., Tang J.J., Liu Q.M., Fang Z.F., Hu X.Q., et al. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty. Circ J 2008, 72:729-733.
9. Liu Z.Y., Zhang J.Y., Sun T.W., Zhang Y.J., Zhang L., Wang L.X. Levels of pregnancy-associated plasma protein A in patients with coronary artery disease. Clin Invest Med 2008, 31:E85-E89.
10. Qin Q.P., Laitinen P., Majamaa-Voltti K., Eriksson S., Kumpula E.K., Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002, 36:358-361.
11. Brugger-Andersen T., Hetland O., Ponitz V., Grundt H., Nilsen D.W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb Res 2007, 119:415-421.
12. Lund J., Qin Q.P., Ilva T., Pettersson K., Voipio-Pulkki L.M., Porela P., et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003, 108:1924-1926.
13. Sanchis J., Bosch X., Bodi V., Bellera N., Nunez J., Benito B., et al. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation. Heart 2008, 94:311-315.
14. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.
15. Westergaard, JG. Studies on Pregnancy associated Plasma Protein-A (PAPP-A) in normal and abnormal Pregnancy Odense university, 1987, DMSc Thesis.
16. Iversen K.K., Teisner A.S., Teisner B., Kliem A., Thanning P., Nielsen H., et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009.
17. Andersen D.C., Koch C., Jensen C.H., Skjodt K., Brandt J., Teisner B. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 2004, 1:17-30.
18. Rossen M., Iversen K., Teisner A., Teisner B., Kliem A., Grudzinskas G. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. Clin Biochem 2007, 40:478-484.
19. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988, 12:56-62.
20. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
21. Little W.C., Applegate R.J. Coronary angiography before myocardial infarction: can the culprit site be prospectively recognized?. Am Heart J 1998, 136:368-370.
22. Little W.C., Constantinescu M., Applegate R.J., Kutcher M.A., Burrows M.T., Kahl F.R., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 1988, 78:1157-1166.
23. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108:1664-1672.
24. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999, 354:708-715.
25. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879-1887.
26. Fox K.A., Poole-Wilson P.A., Henderson R.A., Clayton T.C., Chamberlain D.A., Shaw T.R., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002, 360:743-751.
27. Bertrand M.E., Simoons M.L., Fox K.A., Wallentin L.C., Hamm C.W., McFadden E., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002, 23:1809-1840.
28. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1-e157.
29. Magnus P., Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch Intern Med 2001, 161:2657-2660.
30. Cosin-Sales J., Kaski J.C., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005, 26:2093-2098.
31. Elesber A.A., Conover C.A., Denktas A.E., Lennon R.J., Holmes D.R., Overgaard M.T., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006, 27:1678-1684.
32. Laterza O.F., Cameron S.J., Chappell D., Sokoll L.J., Green G.B. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clinca Chimica Acta 2004, 348:163-169.
33. Lund J., Qin Q.P., Ilva T., Nikus K., Eskola M., Porela P., et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 2006, 38:221-228.
34. Sinosich M.J., Teisner B., Folkersen J., Saunders D.M., Grudzinskas J.G. Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem 1982, 28:50-53.
35. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 2005, 51:75-83.
36. Wittfooth S., Qin Q.P., Lund J., Tierala I., Pulkki K., Takalo H., et al. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. Clin Chem 2006, 52:1794-1801.
37. Terkelsen C.J., Oxvig C., Norgaard B.L., Glerup S., Poulsen T.S., Lassen J.F., et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration. Am J Cardiol 2009, 103:29-35.
38. Tertti R., Wittfooth S., Porela P., Airaksinen K.E., Metsarinne K., Pettersson K. Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A. Clin Chem 2009, 55:1214-1217.
39. Kavsak P.A., Henderson M., Ko D.T., Wang X., MacRae A.R., Jaffe A.S. Another potential marker linking gender and cardiac mortality: PAPP-A-a new marker in risk stratification for women presenting with chest pain. Clin Chim Acta 2009, 408:139-140.